Correction to Lancet Oncol 2015; 16: e227. Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging. [electronic resource]

By: Contributor(s): Producer: 20150917Description: e313 p. digitalISSN:
  • 1474-5488
Online resources: In: The Lancet. Oncology vol. 16
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Published Erratum

There are no comments on this title.

to post a comment.